封面
市场调查报告书
商品编码
1513570

透析机市场 - 按产品类型(血液透析机、腹膜透析机)、最终用途(中心透析、家庭中心透析)全球预测(2024 - 2032)

Dialysis Machines Market - By Product Type (Hemodialysis Machines, Peritoneal Dialysis Machines), By End-use (In-center Dialysis, Home center dialysis) Global Forecast (2024 - 2032)

出版日期: | 出版商: Global Market Insights Inc. | 英文 89 Pages | 商品交期: 2-3个工作天内

价格
简介目录

由于透析机的技术突破、提高效率和病患舒适度以及全球政府积极主动的倡议,2024年至2032年全球透析机市场规模将累积4.3%的复合年增长率。便携式和家庭解决方案等创新满足了患者对便利肾臟护理选择不断增长的需求。政府透过医疗改革和资金提供的支持进一步提高了可近性和负担能力,扩大了市场范围。这些因素共同为日益强大的透析机产业铺平了道路,解决了全球慢性肾臟病日益流行的问题。

例如,2023 年 9 月,KUTRRH 引进了肯亚政府购买的 20 台透析机,这对于复製肾臟功能至关重要。这些设备改变了肾臟护理,使许多患者在肾臟面临挑战的情况下仍能维持生活品质。这一发展显示人们越来越致力于改善医疗基础设施和满足肾臟病患者的需求。它也反映出全球对透析机的需求可能会增加,这是由旨在提高肾臟病患者的治疗可及性和生活品质的类似倡议所推动的。

透析机市场根据产品类型、最终用途和地区进行分类。

到 2032 年,腹膜透析机细分市场将在可及性、成本效益和患者对家庭治疗偏好等方面的优势推动下,获得显着的市场份额。与需要专门中心的血液透析不同,腹膜透析可以在家中进行,提供更大的便利性并减少医疗支出。这些机器有助于持续治疗,确保定期清除体内毒素,而无需频繁去医院。随着医疗保健系统专注于扩大家庭医疗保健选择,腹膜透析机的采用率和市场将持续成长。

由于对以病人为中心的照护选择的需求不断增长,到 2032 年,家庭透析细分市场将建立稳固的立足点。科技的进步使居家透析变得更加容易和高效,使患者能够方便地管理治疗。降低医疗成本、改善治疗结果和更大的患者自主权等因素促进了该细分市场的成长。这一趋势凸显了向个人化医疗保健解决方案的转变,使慢性肾臟病患者能够维持生活质量,同时在舒适的家中管理自己的病情。

到 2032 年,亚太地区透析机产业份额将实现显着的复合年增长率,这归因于医疗保健支出的增加、肾臟疾病盛行率的增加以及医疗保健设施的普及。中国和印度等国家正在见证先进医疗技术的快速采用,而政府改善医疗基础设施的倡议进一步推动了市场成长。此外,人们对肾臟疾病的认识不断提高,农村地区医疗保健服务的改善也使该地区成为全球透析机市场的重要贡献者。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 末期肾病 (ESRD) 患者数量不断增加
      • 糖尿病发生率增加
      • 供肾短缺
      • 透析治疗可获得有利的报销方案
      • 已开发国家及开发中国家的研发投资
    • 产业陷阱与挑战
      • 产品召回
      • 治疗中的併发症
  • 成长潜力分析
  • 居家透析景观
  • 监管环境
  • 报销场景
  • 价值链分析
  • 技术景观
  • 波特的分析
  • PESTEL分析
  • 未来市场趋势

第 4 章:竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章:市场估计与预测:按产品类型,2021 - 2032

  • 主要趋势
  • 血液透析机
  • 腹膜透析机

第 6 章:市场估计与预测:依最终用途,2021 - 2032 年

  • 主要趋势
  • 中心透析
  • 居家透析中心

第 7 章:市场估计与预测:按地区,2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区

第 8 章:公司简介

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Dialife SA
  • Fresenius SE & Co. KGaA
  • JMS Co., Ltd.
  • Medtronic plc
  • Nikkiso Co Ltd.
  • Nipro Corporation
  • Outset Medical, Inc.
  • Quanta Dialysis Technologies Inc.
  • Toray Medical Co., Ltd.
简介目录
Product Code: 9059

Global Dialysis Machines Market size will accumulate a 4.3% CAGR from 2024 to 2032, owing to technological breakthroughs in dialysis machines, enhancing efficiency and patient comfort, in line with proactive government initiatives globally. Innovations such as portable and home-based solutions cater to rising patient demand for convenient renal care options. Government support through healthcare reforms and funding further boosts accessibility and affordability, expanding the market reach. These factors collectively pave the way for an increasingly robust dialysis machines industry, addressing the growing prevalence of chronic kidney diseases worldwide.

For instance, in September 2023, KUTRRH introduced 20 dialysis machines purchased by the Kenyan government, crucial in replicating kidney functions. These devices have transformed renal care, allowing many patients to maintain quality of life despite kidney challenges. This development suggests a growing commitment to improving healthcare infrastructure and addressing the needs of patients with kidney diseases. It also reflects a potential increase in demand for dialysis machines globally, driven by similar initiatives aimed at enhancing treatment accessibility and quality of life for patients suffering from renal conditions.

The dialysis machines market is classified based on product type, end-use, and region.

The peritoneal dialysis machines segment will garner noteworthy market share by 2032, propelled by its advantages in accessibility, cost-effectiveness, and patient preference for home-based treatments. Unlike hemodialysis, which requires specialized centers, peritoneal dialysis can be performed at home, offering greater convenience and reducing healthcare expenditures. These machines facilitate continuous treatment, ensuring regular toxin removal from the body without the need for frequent hospital visits. As healthcare systems focus on expanding home healthcare options, peritoneal dialysis machines will see increased adoption and market growth.

The home dialysis segment will establish a substantial foothold by 2032 due to rising demand for patient-centric care options. Advancements in technology have made home dialysis more accessible and efficient, allowing patients to manage treatments conveniently. Factors such as reduced healthcare costs, improved treatment outcomes, and greater patient autonomy contribute to the segment's growth. This trend underscores a shift towards personalized healthcare solutions, empowering patients with chronic kidney diseases to maintain their quality of life while managing their condition from the comfort of home.

Asia Pacific dialysis machines industry share will register a notable CAGR through 2032, attributed to increasing healthcare expenditure, the growing prevalence of renal disorders, and expanding access to healthcare facilities. Countries like China and India are witnessing rapid adoption of advanced medical technologies, while government initiatives to improve healthcare infrastructure further drive market growth. Additionally, rising awareness about kidney diseases and improving healthcare access in rural areas contribute to the region's prominence as a significant contributor to the global dialysis machines market.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising number of end stage renal diseases (ESRD) patients
      • 3.2.1.2 Increasing incidence of diabetes
      • 3.2.1.3 Shortage of donor kidneys
      • 3.2.1.4 Favorable reimbursement scenario available for dialysis treatment
      • 3.2.1.5 R&D investments in developed as well as developing countries
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Product recalls
      • 3.2.2.2 Complication in the treatment
  • 3.3 Growth potential analysis
  • 3.4 Home dialysis landscape
  • 3.5 Dialysis market, 2021 -2032
  • 3.6 Regulatory landscape
  • 3.7 Reimbursement scenario
  • 3.8 Value chain analysis
  • 3.9 Technological landscape
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis
  • 3.12 Future market trends

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Hemodialysis machines
  • 5.3 Peritoneal dialysis machines

Chapter 6 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 In-center dialysis
  • 6.3 Home center dialysis

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Netherlands
    • 7.3.7 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East and Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 South Africa
    • 7.6.3 UAE
    • 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

  • 8.1 B. Braun Melsungen AG
  • 8.2 Baxter International Inc.
  • 8.3 Dialife SA
  • 8.4 Fresenius SE & Co. KGaA
  • 8.5 JMS Co., Ltd.
  • 8.6 Medtronic plc
  • 8.7 Nikkiso Co Ltd.
  • 8.8 Nipro Corporation
  • 8.9 Outset Medical, Inc.
  • 8.10 Quanta Dialysis Technologies Inc.
  • 8.11 Toray Medical Co., Ltd.